Skip to main content
SpringerLink
Log in

Cimicifuga racemosa Extract Inhibits Proliferation of Estrogen Receptor-positive and Negative Human Breast Carcinoma Cell Lines by Induction of Apoptosis

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Hormone replacement therapy is contraindicated in women with breast cancer. Extracts from the rhizomes of Cimicifuga racemosa, have gained acceptance as a natural alternative for the treatment of menopausal symptoms. In the present study we investigated the antiproliferative activity of C. racemosa extracts (isopropanolic and ethanolic) on the estrogen receptor positive MCF-7 and estrogen receptor negative MDA-MB231 breast cancer cells by WST-1 assay. Down regulation of the proliferative activity and cell killing by isopropanolic and ethanolic extracts occurred in a clear dose-dependent response with a 50% growth inhibitory concentration of 54.1 ± 11.4 and 80.6 ± 17.7 µg/ml in MCF-7 cells and of 29.5 ± 3.0 and 58.6 ± 12.6 µg/ml in MDA-MB231 cells, respectively. Further, the mode of cell death was identified as apoptosis by microscopic inspection and confirmed by light scatter characteristics and by detection of Annexin V adherence to phosphatidylserine by flow cytometry. In addition, the involvement of activated caspases was supported by the cleavage of cytokeratin 18 detected with M30 antibody. Increases in the level of M30-antigen of about 4-fold and 2-fold over untreated controls were observed in C. racemosa-treated MCF-7 and MDA-MB231 cells. These results indicate that C. racemosa extract exerts no proliferative activity, but kills the estrogen receptor positive MCF-7 as well as estrogen receptor negative MDA-MB231 cells by activation of caspases and induction of apoptosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Colditz GA: Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J Natl Cancer Inst 90: 814–823, 1998

    Google Scholar 

  2. Lieberman S: A review of the effectiveness of Cimicifuga racemosa (Black Cohosh) for the symptoms of menopause. J Women's Health 7: 525–529, 1998

    Google Scholar 

  3. Liske E: Therapeutic efficacy and safety of Cimicifuga racemosa for gynecologic disorders. Adv Natural Ther 15: 45–53, 1998

    Google Scholar 

  4. Jarry H, Harnischfeger G, Düker E: Studies on the endocrine effects of the contents of Cimicifuga racemosa, II: in vitro binding of compounds to estrogen receptors. Planta Med 4: 316–319, 1985

    Google Scholar 

  5. Kruse SO, Löhning A, Pauli GF, Winterhoff H, Nahrstedt A: Fukiic and piscidic acid esters from the rhizome of Cimicifuga racemosa and the in vitro estrogenic activity of fukolic acid. Planta Med 65: 763–764, 1999

    Google Scholar 

  6. Liu J, Burdette JE, Xu H, Gu C, van Breemen RB, Bhat KP, Booth N, Constantinou AI, Pezzuto JM, Fong HH, Famsworth NR, Bolton JL: Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem 49: 2472–2479, 2001

    Google Scholar 

  7. Zierau O, Bodinet C, Kolba S, Wulf M, Vollmer G: Antiestrogenic activities of Cimicifuga racemosa extracts. J Steroid Biochem Mol Biol 80: 125–130, 2002

    Google Scholar 

  8. Liske E, Hanggi W, Henneicke-von Zepelin HH, Boblitz N, Wustenberg P, Rahlfs VW: Physiological investigation of a unique extract of black cohosh (Cimicifuga racemosa rhizoma): a 6-month clinical study demonstrates no systemic estrogenic effect. J Womens Health Gend Based Med 11: 163–174, 2002

    Google Scholar 

  9. Bodinet C, Freudenstein J: Influence of Cimicifuga racemosa on the proliferation of estrogen receptor-positive human breast cancer cells. Breast Cancer Res Treat 76: 1–10, 2002

    Google Scholar 

  10. Allred CD, Allred KF, Ju YH, Virant SM, Helferich WG: Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dosedependent manner. Cancer Res 61: 5045–5050, 2001

    Google Scholar 

  11. Zava TD, Dollbaum CM, Blen M: Estrogen and progestin bioactivity of foods, herbs, and spices. Proc Soc Exp Biol Med: 217: 369–378, 1998

    Google Scholar 

  12. Makela S, Davis VL, Tally WC, Korkman J, Salo L, Vihko R, Santti R, Korach KS: Dietary estrogens act through estrogen receptor-mediated processes and show no antiestrogenicity in cultured breast cancer cells. Environ Health Perspect 102: 572–578, 1994

    Google Scholar 

  13. Cohen JJ: Apoptosis. Immunol Today 14: 126–130, 1993

    Google Scholar 

  14. Takahashi A: Caspase: executioner and undertaker of apoptosis. Int J Hematol 70: 226–232, 1999

    Google Scholar 

  15. Leers MP, Kölgen W, Björklund V, Bergman T, Tribbick G, Persson B, Björklund P, Ramaekers FCS, Björklund B, Nap M, Jörnvall H, Schutte B: Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol 187: 567–572, 1999

    Google Scholar 

  16. Ishiyama M, Tominaga H, Shiga M, Sasamoto K, Ohkura Y, Ueno K: A combined assay of cell viability and in vitro cytotoxicity wit a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull 1: 1518–1520, 1996

    Google Scholar 

  17. Bruggisser R, von Daeniken K, Jundt G, Schaffner W, Tullberg-Reinert H: Interference of plant extracts, phytoestrogens and antioxidants with the MTT tetrazolium assay. Planta Med 68: 445–448, 2002

    Google Scholar 

  18. Perry RR, Kang Y, Greaves B: Effects of tamoxifen on growth and apoptosis of estrogen-dependent and-independent human breast cancer cells. Ann Surg Oncol 2: 238–245, 1995

    Google Scholar 

  19. Huang Y, Ray S, Reed JC, Ibrado AM, Tang C, Nawabi A, Bhalla K: Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells. Breast Cancer Res Treat 42: 73–81, 1997

    Google Scholar 

  20. Cappelletti V, Fioravanti L, Miodini P, Di Fronzo G: Genistein blocks breast cancer cells in the G(2)M phase of the cell cycle. J Cell Biochem 79: 594–600, 2000

    Google Scholar 

  21. Hostanska K, Daum G, Saller R: Cytostatic and apoptosisinducing activity of boswellic acids toward malignant cell lines in vitro. Anticancer Res 22: 2853–2862, 2002

    Google Scholar 

  22. Vermes I, Haanen C, Steffens-Nakken H: A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Meth 184: 39–51, 1995

    Google Scholar 

  23. MacFarlane M, Merrison W, Dinsdale D, Cohen GM: Active caspases and cleaved cytokeratins are sequestered into cytoplasmic inclusions in TRAIL-induced apoptosis. J Cell Biol 148: 1239–1254, 2000

    Google Scholar 

  24. Desjardins LM, MacManus JP: An adherent cell model to study different stages of apoptosis. Exp Cell Res 216: 380–387, 1995

    Google Scholar 

  25. Mandlekar S, Kong A-NT: Mechanisms of tamoxifen-induced apoptosis. Apoptosis 6: 469–477, 2001

    Google Scholar 

  26. Sakagami H, Jiang Y, Kusama K, Atsumi T, Ueha T, Toguchi M, Iwakura I, Satoh K, Fukai T, Nomura T: Induction of apoptosis by flavones, flavonols (3-hydroxyflavones) and isoprenoidsubstituted flavonoids in human oral tumor cell lines. Anticancer Res 20: 271–277, 2000

    Google Scholar 

  27. Biven K, Erdal H, Hägg T, Ueno T, Zhou R, Lynch M, Rowley B, Wood J, Zhang C, Toi M, Shoshan MC, Linder S: A novel assay for discovery and characterization of proapoptotic drugs and for monitoring apoptosis in patient sera. Apoptosis 8: 263–268, 2003

    Google Scholar 

  28. Beuscher N: Cimicifuga racemosa L.: Die Traubensilberkerze. Z Phytother 16: 301–310, 1995

    Google Scholar 

  29. Shao Y, Harris A, Wang M, Zhang H, Cordell AG, Bowman M, Lemmo E: Triterpene glycosides from Cimicifuga racemosa. J Nat Prod 63: 905–910, 2000

    Google Scholar 

  30. Dixon-Shanies D, Shaikh N: Growth inhibition of human breast cancer cells by herbs and phytoestrogens. Oncol Rep 6: 1383–1387, 1999

    Google Scholar 

  31. Maggiolini M, Bonofiglio D, Marsico S, Panno ML, Cenni B, Picard D, Ando S: Estrogen receptor-α mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol Pharmacol 60: 595–602, 2001

    Google Scholar 

  32. Yang XH, Sladek TL, Liu X, Butler BR, Froelich CJ, Thor AD: Reconstitution of caspases 3 sensitizes MCF-7 breast cancer cells to doxorubicin-and etoposide-induced apoptosis. Cancer Res 61: 348–354, 2001

    Google Scholar 

  33. Tamaoki T: Use and specificity of staurosporine, UCN-01, and calphostin C as protein kinase inhibitors. Methods Enzymol 201: 340–347, 1991

    Google Scholar 

  34. Xu J, Loo G: Different effects of genistein on molecular markers related to apoptosis in two phenotypically dissimilar breast cancer cell lines. J Cell Biochem 82: 78–88, 2001

    Google Scholar 

  35. Dampier K, Hudson EA, Howells LM, Manson MM, Walker RA, Gescher A: Differences between human breast cell lines in susceptibility towards growth inhibition by genistein. Br J Cancer 85: 618–624, 2001

    Google Scholar 

  36. World Health Organization: World Cancer Report. Steward BW, Kleihues P (eds). IARC Press, Lyon, 2003, pp 188–193

    Google Scholar 

  37. Jensen-Einer N, Zhao J, Andersen KP, Kristoffersen K: Cimicifuga and Melbrosia lack oestrogenic effects in mice and rats. Maturitas 25: 149–153, 1996

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University Hospital Zürich, Zürich, Switzerland

    K. Hostanska & R. Saller

  2. Research and Development Department, Schaper & Brümmer GmbH & Co.KG, Salzgitter, Germany

    T. Nisslein & J. Freudenstein

  3. Institute of Pharmacy and Molecular Biotechnology, University of Heidelberg, Heidelberg, Germany

    J. Reichling

Authors
  1. K. Hostanska
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Nisslein
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Freudenstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Reichling
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Saller
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hostanska, K., Nisslein, T., Freudenstein, J. et al. Cimicifuga racemosa Extract Inhibits Proliferation of Estrogen Receptor-positive and Negative Human Breast Carcinoma Cell Lines by Induction of Apoptosis. Breast Cancer Res Treat 84, 151–160 (2004). https://doi.org/10.1023/B:BREA.0000018413.98636.80

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:BREA.0000018413.98636.80

Search

Navigation